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Abstract. A key symptom in the early stages of Alzheimer’s disease (AD) is the loss of declarative memory. The anatomical
substrate that supports this kind of memory involves the neural circuits of the medial temporal lobe, and in particular, of the
hippocampal formation and adjacent cortex. A main feature of AD is the abnormal phosphorylation of the tau protein and the
presence of tangles. The sequence of cellular changes related to tau phosphorylation and tangle formation has been studied with
an antibody that binds to diffuse phosphotau (AT8). Moreover, another tau antibody (PHF-1) has been used to follow the pathway
of neurofibrillary (tau aggregation) degeneration in AD. We have used a variety of quantitative immunocytochemical techniques
and confocal microscopy to visualize and characterize neurons labeled with AT8 and PHF-1 antibodies. We present here the
rather unexpected discovery that in AD, there is conspicuous abnormal phosphorylation of the tau protein in a selective subset of
dendritic spines. We identified these spines as the typical thorny excrescences of hippocampal CA3 neurons in a pre-tangle state.
Since thorny excrescences represent a major synaptic target of granule cell axons (mossy fibers), such aberrant phosphorylation
may play an essential role in the memory impairment typical of AD patients.
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INTRODUCTION
Alzheimer’s disease (AD) is a progressive neu-
rodegenerative disease partially characterized by the
accumulation of neurofibrillary tangles (NFT) contain-
ing hyperphosphorylated tau, the major protein subunit
of paired helical filaments (PHF) [1]. The memory
deficits provoked in AD may be associated with neu-
ronal loss, which commences in the hippocampal
region and is possibly related to the impaired adult neu-
rogenesis in the dentate gyrus, as it has been reported
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in AD and in some animal models [2]. Newborn neu-
rons form functional synapses with CA3 neurons and
the axons that adult generated dentate gyrus neurons
emit synapse with the thorny excrescences of CA3 neu-
rons [3]. Abnormally phosphorylated tau is the major
component of tangles [1] and this event precedes tau
aggregation. The sequence of cellular changes related
to tau phosphorylation and the formation of tangles has
been studied with a tau antibody that binds to diffuse
phophotau (AT-8) [4]. Moreover, another tau antibody
(PHF-1) has been used to follow the pathway of neu-
rofibrillary (tau aggregation) degeneration in AD [5].
Accordingly, diffuse cytoplasmic PHF-tau reactivity is
thought to reflect an altered neuronal state (pre-tangle)
that precedes the formation of compacted NFT [6].
PHF-tau is typically found in the soma, dendrites, and
axons, although during the course of our microanatom-
ical and neurochemical studies on the brain of AD
patients, we observed an impressive and consistent
Golgi-like labeling of the typical thorny excrescences
of pyramidal cells and mossy cells of the hippocampal
CA3 field (Fig. 1). This Golgi-like labeling was evi-
dent in virtually all neurons with diffuse cytoplasmic
PHF-tau immunostaining. Thus, the main goal of the
present work was to study in detail the PHF-tau pos-
itive dendritic spines in CA3, and to assess whether
dendritic spines are also labeled in those pyramidal
neurons that express PHF-tau in other areas of the hip-
pocampal formation and neocortex. In addition, we
used double labeling immunocytochemistry and con-
focal microscopy to examine whether PHF-tau positive
thorny excrescences are innervated by glutamatergic
terminals.
MATERIAL AND METHODS
Human brain tissue was obtained at autopsy from
two sources: 11 patients with AD (aged 72–94, mean
83.1); and control human brain tissue from 7 individu-
als (aged 23–69, mean 49.4) who died in accidents and
were free of any known neurological or psychiatric ill-
ness (Table 1). The AD brain tissues were obtained
from the Instituto de Neuropatologı´a (Dr. I. Ferrer,
Servicio de Anatomı´a Patolo´gica, IDIBELL-Hospital
Universitario de Bellvitge, Barcelona, Spain) and from
the Banco de Tejidos Fundacio´n CIEN (Dr. A. Ra´bano,
´Area de Neuropatologı´a, Centro Alzheimer, Fundacio´n
Reina Sofia, Madrid, Spain). The control human brains
were obtained from the Servicio de Patologı´a Forense
(Dr. R. Alcaraz, Instituto Vasco de Medicina Legal,
Bilbao, Spain). Following a neuropathological exami-
nation, the patients’ AD stage was defined according to
Braak and Braak [19] (Table 1). Control cases (C1–C7)
were associated with different scores for the amyloid
and neurofibrillary pathologies. While C1 and C5–7
had a Braak score of zero for both pathologies, C2–3
had a few (+) PHF-tauAT8-ir neurons, whereas C4 had
many (+++). Finally, while C2 developed numerous
(+++) plaques immunostained for amyloid- (A),
there were no such plaques in cases C3–4 [20]. In
all cases, the time between death and tissue process-
ing was between 1.5 and 3 h, and the brain samples
were obtained with the approval of and according to
the guidelines of the Institutional Ethical Committee.
Upon removal, the brain tissue was immediately
fixed in cold 4% paraformaldehyde in phosphate buffer
(PB: 0.1 M, pH 7.4) and after 2 h, the tissue was cut
into small blocks and post-fixed in the same fixative
for 24–48 h at 4ºC. After fixation, all the specimens
were immersed in graded sucrose solutions and they
were stored in a cryoprotectant solution at −20ºC.
Serial vibratome sections (50m) of cortical tissue
were obtained, and the sections from each region and
case were batch-processed for immunocytochemical
staining. The sections immediately adjacent to those
stained immunocytochemically were Nissl-stained to
identify the cortical areas to which they pertained and
the laminar boundaries.
Immunohistochemistry
Free-floating sections were pre-treated in 1% H2O2
for 30 min to inactivate the endogenous peroxidase
activity and subsequently, they were blocked for 1 h
in PB with 0.25% Triton-X and 3% normal goat or
horse serum (for polyclonal antisera and monoclonal
antibodies, respectively: Vector Laboratories Inc.,
Burlingame, CA, USA). Single immunohistochem-
istry was performed with the following polyclonal
antiserum or monoclonal antibodies: guinea pig anti-
vesicular glutamate transporter 1 polyclonal antiserum
(VGLUT-1, 1 : 5000, AB5905: Chemicon); mono-
clonal mouse anti-human A antibody (clone 6F/3D
diluted 1 : 50; Dako, Glostrup, Denmark); mouse anti-
human PHF-tau monoclonal antibody (clone AT8,
PHF-tauAT8; 1 : 2000, MN1020: Thermo Scientific;
Waltham, MA, USA); mouse PHF-1 monoclonal anti-
body (PHF-tauPHF-1; 1 : 100, kindly supplied by Dr.
P. Davies); and mouse Tau-1 monoclonal antibody
(1 : 1000, kindly supplied by Dr. L. Binder).
The PHF-tauAT8 antibody is specific for PHF-
tau doubly phosphorylated at Ser202 and Thr205. It
has also been shown to cross-react with tau dou-
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Fig. 1. A) Cajal’s drawing showing pyramidal cells with thorny excrescences in the CA3 [7]. B) Cajal’s original histological preparations from
the rabbit CA3 stained by the Golgi method. C–I), Examples of thorny excrescences on CA3 pyramidal neurons. C–E) Dendrites from a newborn
child’s CA3 pyramidal neurons stained by the Golgi method; F-I) Dendrites on rabbit CA3 pyramidal neurons stained by the Kenyon’s variant of
the Golgi method (preparations housed at the Cajal Institute). Thorny excrescences were named and discovered by Cajal in the apical dendrites
of rabbit CA3 pyramidal neurons [7]. He correctly proposed that these large and often branched structures served as points of contact with the
mossy fibres from the dentate gyrus. The presence of excrescences was later confirmed in a variety of species, including humans, both in the
apical and basal dendrites and in the hilar mossy cells [8–17]. These complex dendritic spines represent a major target of the axon terminals
(mossy fibres) of hippocampal dentate granule cells. The thin unmyelinated mossy fibres form numerous large, en passant swellings and terminal
expansions (giant mossy fibre boutons), which establish numerous synapses with the thorny excrescences [18]. J) PHF-tauAT8-ir CA3 pyramidal
neuron from patient P4 exhibiting a cluster of thorny excrescences (arrow). K–L, N–O) Two focal planes showing thorny excrescences on CA3
PHF-tauAT8-ir cells from the same patient. M and P) Higher magnification of the thorny excrescences (arrows) in L and O, respectively. Q)
Apical dendritic shaft of a type I CA2 PHF-tauAT8-ir pyramidal cell with no labelled dendritic spines. Scale bar (in Q): 55m in B; 11m in
C–I; 25m in J; 20m in K, L, N, O; 4m in M, P; 10m in Q.
bly phosphorylated at Ser199/202 and Ser205/208
[21] while PHF-tauPHF-1 recognizes tau phosphory-
lated at Ser396 and Ser404 [22]. Tau-1 is an antibody
that recognizes a non-phosphorylated epitope of tau
that contains Ser199/Ser202 (of human tau441). The
sections were incubated overnight at 4◦C with the anti-
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Table 1
Summary of case data
AD Age Gender NF/A pathology Postmortem Cause of death
patient Braak stage delay (h)
P1 80 Female AD IV/B 2 -
P2 94 Female AD V/C 1.5 Pulmonary tuberculosis
P3 82 Female AD III/B 3 Pneumonia
P4 80 Female AD III (TAD*) 3 Pseudomembranous colitis plus sepsis and
sancreatic adenocarcinoma
P5 85 Male AD III/A and AGD 2 Pneumonia plus interstitial pneumonitis
P6 88 Female AD III (TAD*) and AGD 2 Bronchopneumonia
P7 91 Male AD III/A and AGD 3 Hepatocarcinoma
P8 72 Male AD I (TAD*) and AGD 2 Bronchopneumonia
P9 82 Male AD V/C 3 Bronchopneumonia plus cardiac failure
P10 85 Male AD V-VI/C 1.5 -
P11 75 Male AD III/B and AGD 2–2.5 Lymphoproliferative disorder
Control NF/A pathology
(autopsies) (hippocampal formation)
C1 23 Male 0 2–3 Traffic accident
C2 49 Male (+)PHF-tauAT8-ir neurons 2–3 Traffic accident
(+++) A plaques
C3 69 Male (+)PHF-tauAT8-ir neurons 2–3 Traffic accident
(0) A plaques
C4 63 Female (+++)PHF-tauAT8-ir neurons 3 Traffic accident
(0) A plaques
C5 36 Male 0 2–2.5 Traffic accident
C6 40 Male 0 3 Traffic accident
C7 66 Male 0 3 Bilateral pneumonia plus cardiac
post-transplant
A, Amyloid-. AGD, Argyrophilic grain disease. NF, Neurofibrillar. TAD*, Tangle-predominant variant of Alzheimer’s disease.
bodies described above (PHF-tauAT8, PHF-tauPHF-1
and Tau-1 immunostaining), and the following day, the
sections were rinsed and incubated for 2 h with biotiny-
lated goat anti-guinea-pig IgG (1 : 200, BA-7000:
Vector Laboratories: VGLUT-1 immunostaining) or
biotinylated horse anti-mouse IgG (1 : 200, BA-2000:
Vector Laboratories). The sections were then incubated
for 1 h in an avidin–biotin peroxidase complex (Vectas-
tain ABC Elite PK6100, Vector), and finally with the
3,3′diaminobenzidine tetrahydrochloride chromogen
(DAB: Sigma-Aldrich, St. Louis, MO, USA). After
staining, the sections were dehydrated, cleared with
xylene and coverslipped. Some slices immunostained
for A and for PHF-tauAT8 were counterstained by the
Nissl technique to visualize the hippocampal strata.
Dual ﬂuorescence immunohistochemistry and
histochemistry
To ascertain the relationship between neurons
immunocytochemically stained for either PHF-tauAT8
or PHF-tauPHF-1, and neurons histochemically labeled
for Thioflavine-S to visualize NFT, some sections
were stained using the same anti-PHF-tauAT8 and
PHF-tauPHF-1 antibodies at the dilutions and incuba-
tion times indicated above. Thereafter, the sections
were incubated for 2 h at room temperature with the
Alexa fluor conjugated goat-anti mouse 594 anti-
body (1 : 2,000, Molecular Probes, Eugene, OR). After
rinsing the sections in PB, they were incubated for
10 min in a 1% solution of Thioflavine-S and they
were then rinsed for 5 min in 100%, 70%, and then
50% ethanol. After rinsing in PB, the sections were
treated with Autofluorescence Eliminator Reagent
(Chemicon) to reduce lipofucsin like-autofluorescence
without adversely affecting any other fluorescent label-
ing in the sections.
To examine the innervation of PHF-tauAT8-ir neu-
rons, some sections were double stained with a mixture
of antibodies VGLUT-1/PHF-tauAT8. The same pri-
mary antibodies, dilutions, and incubation times were
used as those indicated above. Free-floating sections
were incubated overnight at 4◦C in a solution contain-
ing the primary antibodies and then for 2 h at room
temperature with a biotinylated goat anti-guinea pig
antibody for VGLUT-1/PHF-tauAT8 (1 : 200: Vector).
After rinsing in PB, the sections were incubated for
2 h at room temperature with streptavidin coupled to
Alexa fluor 488 (1 : 2,000, Molecular Probes, Eugene,
OR) and with Alexa fluor goat-anti mouse 594. After
rinsing in PB, the sections were treated with the Aut-
ofluorescence Eliminator Reagent.
Finally, the sections were washed and mounted with
ProLong Gold Antifade Reagent (Invitrogen Corpora-
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tion, Carlsbad, CA), and they were examined on a Zeiss
LSM 710 confocal laser scanning system equipped
with an argon/krypton mixed gas laser with excita-
tion peaks at 488 and 594 nm. The fluorescence of
Alexa 488 and 594 was recorded through separate
channels. We obtained image stacks that consisted of
18–49 image planes. Both 40x oil-immersion (NA,
1.25, refraction index, 1.52) and 63x oil-immersion
(NA, 1.40, refraction index, 1.45) lenses were used, in
some cases with a calculated optimal zoom factor 2.3.
Quantitative and statistical analyses
Unbiased stereology was used to quantify total neu-
ron density and PHF-tauAT8-ir neuron density in sec-
tions taken from similar parts of the CA3 hippocampal
region of control and AD patients. The Stereo Investi-
gator software (Microbrightfield, Colchester, VT) was
used to drive a motorized stage (Prior Scientific, Hous-
ton, TX) on a dual optical head microscope (Olympus
BX 51), and to mark neurons at 40x (NA, 0.85) under
brightfield optics. The software sequentially chose ran-
dom counting frames in the xyz axes (60 × 60m and
100 × 100m, to count the total neuron density and
PHF-tauAT8-ir neuron density, respectively), automati-
cally moving the motorized stage within the previously
delimited zones of the CA3 region.
To obtain homogeneous estimates of neuron density,
tissue shrinkage was evaluated using StereoInvestiga-
tor software at five random points in three different
sections of each case to estimate shrinkage in the z
axis of sections after processing for Nissl staining, or in
anti-PHF-tauAT8 stained Nissl counterstained sections.
The number of labeled neurons was estimated using
the optical fractionator method in Stereo Investigator.
Neurons were only marked if their edges lay within
the dissector area and they did not intersect forbidden
lines, and if they came into the focus as the optical plane
moved through the height of the dissector (10m).
The guard zone thickness was set as 3m. This sam-
pling method and the section interval were tested in a
pilot experiment to ensure that the number of neurons
estimated was representative of the total number. The
total neuron density was estimated by counting nucle-
oli in 3–6 Nissl stained sections per case. Neurons with
more than one nucleolus were rare but in such cases,
only one nucleolus was counted. In terms of the density
in PHF-tauAT8-ir neurons, we analyzed 3–6 anti-PHF-
tauAT8 stained and Nissl counterstained sections per
case. In both circumstances, the density obtained was
presented in reference to the total volume estimated in
each counting analysis. The density of PHF-tauAT8-ir
neurons was represented as the percentage with respect
to the total neuron density obtained per case. Further-
more, a BX51 Olympus microscope equipped with a
motorized stage and the Neurolucida package (Micro-
BrightField, Williston, VT, USA) was used to estimate
the density of PHF-tauAT8-ir and PHF-tauPHF-1-ir neu-
rons with different patterns of staining in the CA3.
Using the Neurolucida package, this region was traced
in contiguous Nissl-stained sections with the 4x objec-
tive, and the complete surface was scanned with a 40x
objective in successive and non-overlapping frames of
17,250m2. All the PHF-tauAT8-ir and PHF-tauPHF-1-
ir neurons were recorded and classified as type I or II
(see Table 2).
Spearman’s test was applied to study the possible
correlation between the density of total neurons and
the density of PHF-tauAT8-ir neurons using the Graph-
Pad Prism statistical package (Prism, San Diego, CA,
USA).
RESULTS
Patterns of PHF-tau immunostaining
Thorny excrescences of CA3 neurons were labeled
with the AT8 but not the PHF-1 antibody (Fig. 2),
and we distinguished two patterns of PHF-tauAT8
immunostaining, type I and II [20]. The type I pat-
tern was characterized by diffuse cytoplasmic staining
of neurons with no NFT but with an apparently normal
morphology (Fig. 2 A–C; Fig. 3), although dendrites
and proximal axons often displayed strong Golgi-like
labeling (Fig. 1). Type II neurons contained NFT,
although the amount of somatic cytoplasm occupied
by the NFT varied (Fig. 2 D–F). Accordingly, while
the dendritic arbour of neurons with relatively little
NFT usually displayed numerous dendritic processes,
neurons whose cytoplasm was full of NFT had very
few dendritic processes, suggesting they were under-
going atrophy. Similarly, we also observed type I and
II neurons with the PHF-tauPHF-1 antibody (Fig. 3),
although unlike PHF-tauAT8, the proximal processes
of PHF-tauPHF-1-immunoreactive (-ir) neurons were
less profusely labeled and no thorny excrescences were
stained (Table 2).
We used a Tau-1 antibody that recognizes a non-
phosphorylated epitope of tau to verify that thorny
excrescences were specifically labeled with PHF-
tauAT8, and that no dephosphorylated tau was present in
the thorny excrescences. Neurons were not immunos-
tained for Tau-1, whereas the thorny excrescences of
virtually all type I PHF-tauAT8-ir neurons in adjacent
sections were labeled (Fig. 4). However, when we
examined whether type I PHF-tauAT8-ir neurons had
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Table 2
Labeling of thorny excrescences and density of type I and II PHF-tauAT8-ir neurons (PHF-tauAT8-ir neurons/mm2) and PHF-tauPHF-1-ir neurons
(PHF-tauPHF-1-ir neurons/mm2) in the CA3 field of AD patients and control cases
PHF-tauAT8 PHF-tauPHF-1
AD Type I Thorny Type II Thorny Type I Thorny Type II Thorny
patient excrescences excrescences excrescences excrescences
labeling labeling labeling labeling
P1 0.59 All 0.67 0 0 0 0.49 0
P3 0.41 All 0.13 0 – – – –
P4 0.90 All 0 0 0 0 0.07 0
P5 0.59 All 0 0 0 0 0.33 0
P6 3.41 All 0.16 0 1.31 0 0 0
P7 4.18 All 0.96 0 0.53 0 1.06 0
P8 0 0 0 0 0.09 0 0 0
P9 5.03 All 3.41 0 1.09 0 2.54 0
P10 0.70 All 3.21 0 0 0 6.32 0
P11 2.35 All 0.73 0 0.67 0 0.47 0
Control
C1 0 0 0 0 – – – –
C2 0.14 All 0 0 0.18 0 0.28 0
C3 0 0 0 0 – – – –
C4 2.27 All 0.10 0 0.11 0 0.13 0
C5 0 0 0 0 0 0 0 0
C6 0 0 0 0 – – – –
C7 0 0 0 0 0 0 0.09 0
dendritic spines in other fields of the hippocampal for-
mation and adjacent cortex (the dentate gyrus; CA1 and
CA2 fields; the subiculum, presubiculum, and para-
subiculum; fields of the subicular complex; entorhinal,
perirhinal, and posterior parahippocampal cortex; and
lateral neocortical Brodmann areas 10, 17, 18, 20, 21,
24), this was not the case in any of these regions (Fig. 1
Q). Thus, thorny excrescences are specifically labeled
with PHF-tauAT8 in the CA3, suggesting that abnor-
mal phosphorylation of tau in thorny excrescences is
particularly relevant in AD.
Possible relationships between patterns of
PHF-tau staining, neuronal loss, the presence of
amyloid plaques, and labeling of thorny
excrescences
Unbiased stereology was used to quantify the total
neuron density and PHF-tauAT8-ir neuron density in the
CA3 field of control and AD patients, and the density of
PHF-tauAT8-ir neurons was represented as a percentage
with respect to the total neuron density obtain per case
(Fig. 5). No correlation was found between the den-
sity of total neurons and the density of PHF-tauAT8-ir
neurons (Spearman’s rho −0.3766; P = 0.3125). Fur-
thermore, we estimated the density of PHF-tauAT8- and
PHF-tauPHF-1-ir neurons classified as displaying a type
I or II pattern of immunostaining in the CA3 in each
case (Fig. 6). By taking into account the data from
Table 2 (see also Fig. 6), the highest density of pattern
II PHF-tauAT8-ir neurons were present at later stages
of the disease, whereas the majority of these neurons
displayed pattern I in earlier stages. In the case of PHF-
tauPHF-1-ir cells, the number and proportion of neurons
with pattern I staining was relatively low at all stages,
whereas numerous neurons with pattern II were found
at later stages. Thus, the highest density of neurons
with pattern II was found in the later stages.
The presence of PHF-tauAT8-ir thorny excrescences
in CA3 neurons was independent of the intensity
and number of PHF-tauAT8-ir processes in the hip-
pocampus and dentate gyrus. Indeed, there was highly
variable PHF-tauAT8 labeling in these structures,
despite the presence of PHF-tauAT8-ir thorny excres-
cences (Fig. 7).
Some PHF-tauAT8-ir thorny excrescences were so
large that they had a dystrophic appearance when
compared to those present in other adjacent neurons
(Fig. 8C–E). Since amyloid plaques induce mor-
phological changes in dendritic spines [23–26], we
wondered if the presence of these giant thorny excres-
cences could reflect the fact that amyloid plaques were
in contact or adjacent to these PHF-tauAT8-ir neurons.
Thus, adjacent sections to those stained for PHF-
tauAT8 were processed to visualize amyloid plaques
(Fig. 8A). Comparing the distribution of PHF-tauAT8-
ir neurons and plaques revealed no such a correlation,
since there were cases showing very few plaques
in CA3 but a relatively large number PHF-tauAT8-ir
neurons with large thorny excrescences (Fig. 8).
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Fig. 2. Confocal microscopy of neurons from patient P7 double stained with an anti-PHF-tauAT8 antibody (A–F) or an anti-PHF-tauPHF-1
antibody (red, G–I), and with Thioflavine-S (TS, green) to label PHF-tau forming NFT. A–C) a type I CA3 neuron stained with PHF-tauAT8 but
not forming NFT (stack of 41 confocal optical sections, step size: 0.6m). Arrows indicate some thorny excrescences. D–F) A type II where
TS co-localizes with PHF-tauAT8. Note the presence of an apical dendrite (stack of 36 confocal optical sections, step size: 0.6m). G–I) A type
II neuron where TS co-localizes with PHF-tauPHF-1 (stack of 28 confocal optical sections, step size: 0.45m). Scale bar (in I): 58m in A–I.
Finally, to test whether tau phosphorylation corre-
lates with a loss of synaptic connectivity, we examined
glutamatergic (VGLUT-1) axon terminals to determine
whether they innervated thorny excrescences of PHF-
tauAT8-ir neurons. Apparently normal VGLUT-1-ir
boutons were in direct apposition to the PHF-tauAT8-ir
thorny excrescences, suggesting a “normal” connec-
tivity (Fig. 9). Hence, tau phosphorylation in thorny
excrescences is likely to be an early marker and a
reversible even.
DISCUSSION
The main finding in the present study is that the typ-
ical thorny excrescences of CA3 neurons are labeled
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Fig. 3. Low-power photomicrographs of sections from the hippocampal formation of patient P9 stained with PHF-tauAT8 (A) and PHF-tauPHF-1
(B). C and D) Higher magnification of the CA3 field in A and B, respectively. Arrows indicate some labeled neurons. Note that the density
of PHF-tauAT8-ir neurons is higher than that of PHF-tauPHF-1-ir neurons. E and F) Higher magnification of the boxed CA1 fields in A and B,
respectively. G–J) Higher magnification of PHF-tauAT8-ir (G, H) and PHF-tauPHF-1-ir (I–J) type I (G and I) and II (H and J) stained neurons.
Scale bar (in J): 1600m in A, B; 320m in C–F; 35m in G–J.
selectively using the AT8 but not the PHF-1 anti-
body. Thus, these particular dendritic spines must be
involved in specific activities that fail in AD.
Expression of PHF-tau in thorny excrescences
We observed numerous CA3 neurons with their
thorny excrescences clearly labeled by the AT8 (PHF-
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Fig. 4. A and B) Low-power photomicrographs of sections from the hippocampal formation of patient P5 stained with PHF-tauAT8 (A) and
Tau-1 (antibody against non-phosphorylated tau protein) (B). The arrows in A indicate the cells shown at higher magnification in C and D. E
and F) Examples of thorny excrescences PHF-tauAT8-ir observed in C and D, respectively. Scale bar (in F): 400m in A–B; 43m in C–D;
11m in E; 23m in F.
tauAT8) antibody. Despite the wealth of studies of AD,
it is surprising that PHF-tauAT8-ir thorny excrescences
have not been described before. It is possible that
they have passed unnoticed when labeled previously
or that technical issues influence their labeling with
this antibody. For example, it is common to use for-










Fig. 5. A) Graph showing the density of total neurons (total neurons/mm3) in control cases (white columns) and AD patients (black columns)
with different NF stages. In the top of the bars is indicated the age of each individual. B) Graph showing the percentage of PHF-tauAT8-ir neurons
in the same cases.
Fig. 6. Graphs showing the density of PHF-tauAT8-ir (A) and PHF-tauPHF-1-ir neurons (B) in the CA3 field from control cases and AD patients
with different NF stages.
malin (10%) fixed, paraffin embedded tissue, heated
in a microwave oven prior to immunocytochemical
staining. By contrast, we used vibratome sections of
fresh brain tissue fixed in paraformaldehyde (4%)
and immunocytochemistry was performed in free-
floating sections. Furthermore, the post-mortem period
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Fig. 7. Photomicrographs of anti-PHF-tauAT8 stained sections counterstained with the Nissl technique showing different fields of the hippocampal
formation of patients P9 (A) and P10 (B). Boxed areas in A and B correspond to panels H and E, respectively. C–H) Higher magnification of
the dentate gyrus of patients P6, P5, P10, P7, P11 and P9, respectively. Scale bar (in H): 700m in A, B; 130m in C–H. gran = granular layer;
mol = molecular layer; pol = polymorphic layer.
of autopsy samples (10–18 h) is significantly longer
than in our own research (less than 3 h). Whatever the
reason, we consistently observed PHF-tauAT8-ir thorny
excrescences in the CA3 field of patients at different
stages of AD, ages, and gender, using immunoperoxi-
dase or immunofluorescence methods (Table 1). Since
we examined relatively few cases (n = 11), we consider
this finding to be very robust in the general population
of AD patients.
Evolution of the alterations to the tau protein and
of the labeling of thorny excrescences
In the AD brain, 45 different sites in the tau
molecule can be phosphorylated [27], some of which
can be identified by different antibodies like AT8
(S199/S202/T205) or PHF-1 (S396/S404). This phos-
phorylation at different sites seems to occur in a
sequentially ordered cascade during the progression
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Fig. 8. Amyloid- plaques and labeling of thorny excrescences. A and B) Photomicrographs illustrating the distribution of A plaques in a Nissl
counterstained section and of PHF-tauAT8-ir neurons in the CA3 field of an adjacent section from patient P9. C–E) High-power photomicrographs
of some type I PHF-tauAT8-ir neurons highlighted by boxes in B. Note that there are relatively few A plaques in CA3 (arrows in A), whereas
numerous neurons show type I PHF-tauAT8-ir with labeled thorny excrescences (C–E). Scale bar (in E): 198m in A, B; 25m in C–E.
of the disease. Indeed, it has been proposed that at
the level of individual neurons, there is an early stage
(termed the pre-tangle stage) that is characterized by
the accumulation of PHF-tau protein in the somato-
dendritic domain of affected neurons. These neurons
are non-argyrophilic and therefore they can only be
detected with anti-PHF-tau antibodies. The next stage
involves the appearance of classic intracellular NFT,
while in the final stage ghost NFT accumulate, defined
as NFT located “freely” in the neuropil with no rela-
tionship to a neuronal soma [4, 28]. Previous studies
have shown that interaction with the AT8 antibody
is frequently observed in neurons of patients at an
early stage of the disease, whereas PHF-1 epitopes are
more frequently observed at later stages of the disease
[29–32].
In the present work, we found that the highest den-
sity of pattern II PHF-tauAT8-ir neurons were present at
later stages of the disease, whereas in the earlier stages
the majority of PHF-tauAT8-ir neurons displayed pat-
tern I. When considering PHF-tauPHF-1-ir cells, there
are always relatively few type I neurons, whereas the
number of type II neurons increases at later stages
such that the highest density and proportion of type
II neurons were found in the later stages. This obser-
vation is in line with previous indications suggesting
that the phosphorylation of tau at the site recognized
by AT8 (mostly pre-tangle neurons) precedes that of
PHF-1 phosphorylation (mostly neurons with tangles).
Our dual fluorescence immunohistochemistry and his-
tochemistry indicates that type I staining is due to the
accumulation of unpolymerized PHF-tau, whereas the
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Fig. 9. A and B) Stacks of 49 confocal optical sections (A) and 29 optical sections (B) (step size: 0.5 and 0.8m, respectively) from type
I PHF-tauAT8-ir pyramidal neurons in the CA3 of patients P4 and P7, respectively. Squares in A and B indicate the regions shown at higher
magnification in C–E (4 confocal optical sections, step size: 0.46m) and F–H (3 confocal optical sections, step size: 0.80m), respectively,
illustrating the VGLUT-1-ir glutamatergic axon terminals (green) that innervate dendritic excrescences of PHF-tauAT8-ir pyramidal neurons
(red). Scale bar (in H): 23m in A, B; 7m in C–H.
type II pattern is due to the accumulation of poly-
merized PHF-tau into NFT. Therefore, it seems that
PHF-tauAT8 and PHF-tauPHF-1-ir type I neurons rep-
resent pre-tangle stages and the type II neurons are in
tangle stages. However, we cannot rule out the possibil-
ity that these neurons represent independent stages and
not a sequence in the destruction of the cytoskeleton
in individual neurons.
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Possible functional signiﬁcance of aberrant tau
phosphorylation in thorny excrescences
Tau is a microtubule-associated protein, whereas
dendritic spines have an actin-based cytoskeleton.
However, the presence of microtubule proteins in
spines, like tau, could be explained by the occasional
presence of microtubules in longer CA3 dendritic
spines [33, 34]. Moreover, microtubules could be
present transiently in spines, and they may play a role
in the control and regulation of dendritic spine devel-
opment and plasticity [35]. In addition, F-actin is an
important component of dendritic spines [36] and tau-
induced degeneration may provoke the accumulation
of F-actin, leading to a direct interaction between tau
and actin [37]. We now suggest that dendritic spine
plasticity could be modified by the presence of PHF-
tau, a phosphoprotein that could remain in the spine
due to its interaction with cofilin [38]. In addition,
it was recently indicated that tau mislocation to den-
dritic spines mediates synaptic dysfunction in mouse
models [39]. PHF-tauAT8, like proline directed phos-
phorylation, could induce the mislocalization of tau
to dendritic spines, where it impairs excitatory synap-
tic transmission through the loss of functional surface
glutamate receptors [39]. Furthermore, an association
of the tau protein with the PSD complex has been
reported, concentrating NMDA receptors to PSD95
[40]. All these results suggest a role for tau in dendrites
in those mouse models, although we cannot exclude
that a similar mechanism to that reported by Hoover
et al. [39] could occur in the AD patients studied
here.
We do not know the principal cause for tau phospho-
rylation at the site recognized by the AT8 antibody,
although A oligomers may activate GSK3 [41, 42]
that is the kinase that modifies the AT8 site [27].
However, we have not found a correlation between
A plaques and the labeling of thorny excrescences,
although we cannot rule out that small oligomers
induce tau phosphorylation in these particular dendritic
spines. Whatever the mechanism, thorny excrescences
are a major synaptic target of granule cell (mossy
fibers) axons, which receive most of their extrinsic
input from layer II neurons of the entorhinal cor-
tex and participate in a critical pathway to transfer
neocortical representations to the hippocampus [18].
Therefore, these structures may play an essential role
in the memory impairment typical of AD patients.
Indeed, although glutamatergic innervation of these
spines seems to remain unchanged, alterations in the
synaptic connections may exist at the physiological
level, and further studies on animal models will be
necessary to resolve this question.
The studies of the relationship between synaptic
plasticity and modifications in tau phosphorylation
in the European ground squirrel [43] may be rele-
vant when interpreting the present results. In these
animals, synapses of mossy fibers onto CA3 hip-
pocampal neurons undergo cyclic changes during
hibernation and arousal such that there is a partial
denervation of CA3 pyramidal neurons during tor-
por that is fully and rapidly reversed during euthermy
[44]. There is an induction of PHF-like phospho-
rylation in the brain when these animals hibernate,
which is similar to the characteristic increase in tau
phosphorylation [45]. Furthermore, the changes in the
denervation/reinnervation of CA3 pyramidal neurons
by mossy fibers during hibernation/arousal are associ-
ated with reversible PHF-like phosphorylation of tau
that occurs over a similar time course. Thus, the forma-
tion and degradation of PHF-like tau might represent
a physiological mechanism not necessarily associated
with pathological effects but rather with neuronal plas-
ticity.
Intriguingly, the aberrant phosphorylation of thorny
excrescences observed here might be induced by
the failure of synaptic connections or by diminished
synaptic activity of neurons in the dentate gyrus and
CA3. Such changes may be due to the impairment
of entorhinal connections with the dentate gyrus,
which could produce the early alterations in declara-
tive memory in AD patients. Nevertheless, the presence
of CA3 neurons with PHF-tauAT8-ir thorny excres-
cences was independent of the intensity and number
of PHF-tauAT8-ir processes present in the outer two-
thirds of the molecular layer in the dentate gyrus, a
major site where layer II entorhinal neurons termi-
nate [46]. However, physiological alterations to the
entorhinal/hippocampus connections may precede the
expression of PHF-tau in the entorhinal axons that ter-
minate in the dentate gyrus.
In conclusion, we demonstrate the presence PHF-
tau in thorny excrescences in the brain of AD patients.
This is a novel feature of AD and it could be a very
early marker of disease onset, possibly representing
the first step in impaired synaptic transmission [39].
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